Clinical Virology

Medicine & Life Sciences

1. Hepacivirus 100%
2. Antiviral Agents 35%
3. Virus Diseases 32%
4. Hepatocytes 19%
5. Monoclonal Antibodies 18%
6. Liver 17%
7. Virion 15%
8. lysosomal Pro-X carboxypeptidase 12%
9. Viruses 12%
10. Infection 12%
11. Hepatitis C Antibodies 12%
12. CD36 Antigens 12%
13. fibroblast activation protein alpha 11%
14. Life Cycle Stages 11%
15. Peptide Hydrolases 11%
16. Monkeypox virus 11%
17. In Vitro Techniques 11%
18. Animal Models 11%
19. Influenzavirus C 11%
20. prolyl oligopeptidase 10%
21. Liver Transplantation 10%
22. Carboxypeptidase B2 10%
23. Virus-Like Particle Vaccines 10%
24. Virus Internalization 10%
25. Lipoproteins 10%
26. HIV 10%
27. Liver Diseases 10%
28. Flunarizine 9%
29. Genotype 9%
30. Coronavirus Infections 9%
31. Claudin-1 9%
32. Classical Complement Pathway 9%
33. Alternative Complement Pathway 9%
34. Belgium 9%
35. Dipeptidyl Peptidase 4 9%
36. Hepatitis E virus 9%
37. Animal Diseases 8%
38. Severe Acute Respiratory Syndrome 8%
39. Coronavirus 8%
40. Hepatitis C 8%
41. Neutralizing Antibodies 8%
42. Sexual Health 7%
43. Capsid 7%
44. Therapeutics 7%
45. Tyrosine 7%
46. Apolipoproteins E 7%
47. Syphilis 7%
48. Interleukins 7%
49. Proline 7%
50. Hemolysis 6%
51. Antibodies 6%
52. Secondary Prevention 6%
53. Tight Junction Proteins 6%
54. RNA Interference 6%
55. Developed Countries 6%
56. Transplants 6%
57. Histones 6%
58. Natural Killer Cells 6%
59. Edetic Acid 5%
60. Monocytes 5%
61. interferon type III 5%
62. Virus Receptors 5%
63. Chronic Hepatitis C 5%
64. Interferons 5%
65. Ribavirin 5%